background
indoor
pollut
allergen
includ
hous
dust
mite
influenc
asthma
control
level
object
determin
rate
allergi
hous
dust
allergen
impact
associ
indoor
pollut
asthma
control
level
method
studi
questionnair
total
ige
test
skin
test
allerg
hous
dust
collect
children
asthma
enrol
januari
march
diagnosi
assess
asthma
control
level
child
determin
accord
gina
criteria
result
children
posit
skin
test
least
one
indoor
respiratori
allergen
remain
children
neg
skin
test
posit
group
posit
allergen
posit
proport
dermatophagoid
pteronyssinu
dermatophagoid
farina
highest
follow
hous
dust
allergen
blomia
cockroach
hairi
dog
lowest
rate
account
cat
fur
rate
posit
allergen
test
children
year
age
higher
children
year
p
similarli
rate
posit
allergen
test
children
total
ige
iuml
higher
children
total
ige
p
children
posit
allergen
test
uncontrol
partli
control
asthma
higher
group
children
neg
allergen
test
p
similarli
children
posit
test
two
allergen
uncontrol
partli
control
asthma
higher
group
children
posit
test
one
allergen
p
indoor
pollut
tend
associ
increas
risk
uncontrol
partli
control
asthma
particularli
irregular
bed
hygien
per
month
p
charcoal
fume
p
smoke
p
dog
cat
ownership
p
respect
remain
element
live
citi
countrysid
famili
hous
area
slightli
averag
whether
play
stuf
anim
associ
increas
risk
uncontrol
partli
control
asthma
conclus
rate
children
asthma
high
posit
skin
prick
test
respiratori
allergen
hous
dust
mite
irregular
bed
hygien
less
per
month
charcoal
fume
smoke
pollut
dog
cat
ownership
found
associ
increas
risk
uncontrol
partli
control
asthma
backgroundaim
bronchial
hyperrespons
intermedi
phenotyp
asthma
bronchial
respons
exist
dichotom
express
hyper
rather
exist
spectrum
aim
evalu
distribut
profil
bronchial
respons
korean
gener
popul
relationship
clinic
allergi
method
birth
cohort
particip
invit
visit
region
studi
hospit
perform
skin
prick
test
standard
spirometri
bronchial
provoc
test
well
detail
histori
physic
examin
subject
bronchial
respons
categor
one
five
order
group
well
pediatr
pulmonolog
wileyonlinelibrarycomjournalppul
wiley
period
inc
logtransform
respons
dose
ratio
rdr
continu
marker
airway
respons
distribut
frequenc
preval
recent
wheez
baselin
lung
function
preval
atop
sensit
across
five
group
well
rdr
associ
clinic
allergi
assess
result
among
birthcohort
particip
children
visit
studi
hospit
subject
reliabl
complet
bronchial
provoc
test
ten
percent
total
popul
show
provoc
concentr
inhal
methacholin
caus
fall
forc
expiratori
volum
second
mgml
group
present
mgml
group
total
show
mgml
time
mgml
group
display
mgml
mgml
well
group
final
present
mgml
group
group
sampl
increas
proport
subject
wheezi
episod
last
year
decreas
p
trend
proport
subject
sensit
panel
allergen
decreas
p
trend
wherea
mean
baselin
percentagepredict
increas
p
hand
rdr
present
signific
elong
current
asthmat
other
p
also
trend
toward
increas
rdr
across
control
allerg
rhiniti
asthma
combin
allerg
rhiniti
asthma
group
p
gener
popul
wide
spectrum
bronchial
respons
bronchial
respons
age
associ
clinic
allergi
name
neg
baselin
lung
function
posit
atop
sensit
accord
nationwid
databas
pediatr
intens
care
unit
picu
admiss
number
children
requir
intens
care
admiss
sever
acut
asthma
saa
increas
saa
potenti
progress
respiratori
failur
fatal
saa
requir
admiss
picu
repres
major
cost
burden
addit
picu
admiss
associ
greater
psycholog
morbid
children
parent
compar
admiss
gener
pediatr
ward
object
aim
studi
identifi
factor
explain
increas
picu
admiss
netherland
method
perform
multicent
retrospect
cohort
studi
across
tertiari
care
picu
netherland
retrospect
analyz
number
characterist
children
hospit
saa
picu
period
netherland
inclus
criteria
children
age
year
hospit
saa
picu
netherland
children
younger
year
includ
uncertainti
diagnosi
saa
diagnosi
confirm
picu
discharg
admiss
readmiss
includ
studi
data
includ
demographi
saa
treatment
refer
hospit
picu
mortal
result
studi
period
children
admit
picu
total
admiss
picu
admiss
patient
studi
receiv
intraven
iv
salbutamol
dutch
asthma
guidelin
requir
picu
admiss
case
iv
salbutamol
given
patient
receiv
salbutamol
infus
rate
mcgkgmin
less
receiv
higher
infus
rate
mcgkgmin
fortytwo
per
cent
admit
children
year
old
fortyfour
children
admit
saa
number
remain
rel
stabl
sinc
annual
number
patient
admit
picu
gradual
increas
age
distribut
sever
saa
base
first
blood
ga
length
stay
picu
remain
unchang
number
children
asthma
tripl
sinc
year
proport
patient
admit
picu
increas
gradual
although
fewer
children
necessit
invas
ventil
highflow
nasal
cannula
optiflow
introduc
use
increas
significantli
follow
year
seven
patient
need
extracorpor
membran
oxygen
ecmo
inhospit
mortal
n
conclus
last
decad
observ
threefold
increas
children
saa
admit
picu
netherland
age
distribut
sever
ill
remain
similar
new
nation
guidelin
picu
admiss
mandatori
use
iv
salbutamol
specul
observ
explain
implement
nation
saa
guidelin
increas
undertreat
inhal
steroid
reflect
concret
propos
action
prioriti
given
adequ
diagnosi
treatment
children
asthma
prevent
picu
admiss
carri
high
cost
associ
risk
posttraumat
stress
disord
prospect
studi
risk
factor
children
saa
requir
salbutamol
iv
need
safeti
salbutamol
iv
studi
need
picu
admiss
reconsid
asthma
common
chronic
inflammatori
diseas
respiratori
tract
children
qualiti
life
children
suffer
asthma
subject
experi
satisfact
dissatisfact
live
main
aim
studi
verifi
connect
symptom
asthma
lung
function
qualiti
life
influenc
comorbid
asthma
qualiti
life
identifi
quantifi
psychosoci
area
children
perceiv
handicap
due
ill
verifi
degre
similar
percept
qualiti
life
parent
children
asthma
also
aim
studi
translat
adopt
valid
serbian
languag
junip
questionnair
name
paqlq
pediatr
asthma
qualiti
life
questionnair
standard
oper
variant
examin
questionnair
regard
qualiti
life
caregiv
children
asthma
pacqlq
pediatr
asthma
caregiv
qualiti
life
questionnair
use
questionnair
want
verifi
qualiti
life
children
asthma
parent
result
analyz
accord
sever
length
diseas
well
paramet
degre
diseas
accord
gina
spirometri
comorbid
etc
studi
includ
children
year
old
intermitt
persist
mild
moder
asthma
studi
patient
also
classifi
accord
asthma
control
score
diagnosi
asthma
establish
use
well
known
guidelin
diagnosi
manag
asthma
registr
detail
medic
histori
taken
physic
examin
perform
patient
well
pulmonari
function
measur
upon
arriv
control
examin
week
asthma
control
score
obtain
interview
children
asthma
parent
organ
paqlq
includ
question
divid
three
area
limit
activ
symptom
emot
function
pacqlq
contain
question
divid
two
main
area
restrict
perform
activitiesa
emot
function
question
questionnair
possibl
answer
grade
mean
abstract
without
symptom
complaint
grade
mean
promin
symptom
signific
correl
stage
asthma
symptom
lung
function
qualiti
life
children
involv
studi
clinic
pictur
significantli
affect
qualiti
life
children
children
poorer
control
diseas
poorer
qualiti
life
also
improv
diseas
control
asthma
control
score
led
improv
qualiti
life
particularli
area
symptom
f
p
emot
function
f
p
comorbid
asthma
allerg
diseas
much
present
children
isol
asthma
better
qualiti
life
children
asthma
allerg
rhiniti
vs
p
parent
children
percept
diseas
coeffici
correl
r
p
r
p
r
p
parent
assess
person
qualiti
life
significantli
wors
children
p
p
p
children
involv
studi
complaint
area
symptom
cough
limit
physic
activ
element
often
cite
emot
disturb
less
pronounc
sens
reject
significantli
perturb
patient
involv
studi
questionnair
assess
qualiti
life
children
asthma
translat
serbian
show
good
discrimin
capabl
high
reliabl
specif
cronbach
alpha
may
recommend
assess
qualiti
life
routin
medic
practic
clinic
trial
instrument
current
avail
use
children
research
encourag
verifi
valid
use
use
questionnair
comprehens
health
outcom
measur
children
result
obtain
studi
promot
introduct
tool
measur
qualiti
life
import
paramet
estim
stage
diseas
accept
asthma
symptom
patient
background
asthma
lead
caus
childhood
morbid
episod
diseas
worsen
exacerb
lead
hospit
impact
qualiti
life
tiotropium
addon
therapi
demonstr
improv
peak
trough
forc
expiratori
volum
second
adolesc
children
symptomat
asthma
despit
inhal
corticosteroid
ic
treatment
control
howev
clear
impact
episod
asthma
worsen
treatment
may
improv
describ
lung
function
outcom
pediatr
patient
experienc
episod
asthma
worsen
compar
phase
iii
trial
children
adolesc
method
post
hoc
analys
involv
phase
iii
random
doubleblind
placebocontrol
parallelgroup
trial
cover
patient
age
year
canotinavivatinaasthma
moder
sever
asthma
respect
year
rubatinapensietinaasthma
moder
sever
asthma
respect
patient
receiv
oncedaili
tiotropium
placebo
deliv
puff
via
respimat
inhal
addon
ic
control
primari
endpoint
studi
peak
chang
baselin
respons
within
hour
postdos
week
sever
moder
asthma
respect
secondari
endpoint
includ
trough
respons
key
pensietinaasthma
canotinaasthma
vivatinaasthma
measur
end
dose
interv
minut
next
dose
trial
medic
week
sever
moder
asthma
respect
peak
trough
respons
patient
experienc
episod
asthma
worsen
trial
compar
patient
experi
asthma
worsen
trial
asthma
worsen
defin
episod
progress
increas
asthma
symptom
compar
usual
daytoday
asthma
symptom
consecut
day
decreas
patient
best
morn
pef
patient
mean
morn
pef
least
consecut
day
also
includ
definit
analys
use
restrict
maximum
likelihoodbas
mixedeffect
model
repeat
measur
result
baselin
demograph
diseas
characterist
gener
balanc
experienc
episod
asthma
worsen
screen
treatment
period
studi
within
specifi
age
asthma
sever
group
across
studi
improv
baselin
peak
trough
respons
placebo
arm
improv
gener
lower
patient
experienc
episod
asthma
worsen
dose
tiotropium
improv
peak
trough
respons
excess
seen
placebo
observ
children
irrespect
whether
experienc
episod
asthma
worsen
studi
respons
slightli
variabl
studi
particularli
asthma
worsen
subgroup
possibl
due
low
number
patient
figur
overal
adolesc
placeboadjust
improv
lung
function
observ
tiotropium
patient
background
systemat
literatur
review
pediatr
patient
asthma
compar
improv
forc
expiratori
abstract
volum
second
tiotropium
respimat
ad
inhal
corticosteroid
ic
improv
report
longact
laba
ad
ic
method
endpoint
select
comparison
peak
trough
respons
ie
chang
baselin
liter
systemat
literatur
search
perform
identifi
relev
public
report
random
control
trial
laba
ad
ic
least
week
adolesc
children
result
compar
result
phase
iii
trial
tiotropium
respimat
ad
ic
pediatr
patient
asthma
rubatinaasthma
canotinaasthma
result
systemat
literatur
search
trial
investig
laba
ad
ic
pediatr
patient
identifi
relev
public
includ
cochran
metaanalysi
detail
trial
trial
tiotropium
respimat
pediatr
patient
asthma
provid
tabl
laba
studi
mean
ic
dose
baselin
rang
budesonid
equival
fluticason
propion
tiotropium
studi
mean
ic
dose
baselin
rang
budesonid
equival
laba
studi
includ
cochran
metaanalysi
present
combin
peak
trough
measur
articl
specifi
time
point
measur
taken
laba
ad
ic
versu
ic
cochran
metaanalysi
year
peak
respons
schmidt
annual
congress
random
doubleblind
parallelgroup
multicent
trial
year
peak
respons
abstract
csr
clinic
studi
report
forc
expiratori
volum
second
ic
inhal
corticosteroid
laba
longact
na
applic
pef
peak
expiratori
flow
figur
treatment
differ
respons
laba
compar
placebo
ad
ic
includ
cochran
metaanalysi
point
repres
mean
treatment
differ
versu
placebo
bar
repres
ci
treatment
differ
favor
laba
ad
ic
ic
alon
ci
confid
interv
ic
inhal
corticosteroid
laba
longact
figur
treatment
differ
peak
trough
b
respons
tiotropium
respimat
placebo
ad
ic
abstract
point
repres
mean
treatment
differ
versu
placebo
bar
repres
ci
treatment
differ
favor
tiotropium
placebo
ci
confid
interv
histori
breastfeed
median
minimum
maximum
eosinophil
screen
cellsl
median
minimum
maximum
total
ige
screen
abstract
hr
hazard
ratio
ic
inhal
corticosteroid
pbo
placebo
tior
tiotropium
abstract
conclus
analysi
suggest
treatment
tiotropium
reduc
ae
relat
asthma
exacerb
symptom
pediatr
patient
particular
effect
reduc
spring
autumn
season
peak
longterm
asthma
exacerb
trial
pediatr
patient
remain
ethic
challeng
analysi
highlight
altern
endpoint
investig
efficaci
children
data
also
highlight
import
trial
time
account
season
exacerb
peak
studi
length
practic
background
asthma
common
chronic
diseas
children
guidelin
therapi
often
result
partial
symptom
control
despit
high
unmet
need
new
treatment
rel
new
therapi
approv
age
group
within
last
decad
review
endpoint
current
use
clinic
trial
pediatr
patient
asthma
includ
lesson
tiotropium
asthma
clinic
program
aim
encourag
facilit
futur
clinic
trial
pediatr
patient
asthma
method
recent
literatur
field
pediatr
clinic
trial
asthma
review
particular
focu
place
find
tiotropium
respimat
pediatr
clinic
trial
program
patient
age
abstract
etiolog
aspect
asthma
exacerb
childhood
markova
r
pediatr
pediatr
consult
clinic
sofia
bulgaria
main
caus
asthma
exacerb
childhood
viral
infect
etiolog
profil
signific
epidemiolog
therapeut
valu
materi
method
clinic
survey
oneyear
period
patient
bronchial
asthma
follow
age
abstract
year
patient
investig
accord
clinic
function
laboratori
paramet
order
assess
certain
etiolog
aspect
asthma
exacerb
serolog
test
perform
elisa
test
rsv
adenoviru
chlamydia
pneumonia
mycoplasma
pneumonia
influenza
viru
parainfluenza
viru
igm
igg
antibodi
result
result
evalu
use
statist
method
spss
softwar
result
demonstr
asthmat
acut
rsv
infect
found
posit
igm
antibodi
data
past
rsv
infect
posit
igg
antibodi
patient
acut
adenoviru
infect
posit
igg
antibodi
detect
asthmat
posit
igg
titer
chlamydia
pneumonia
found
patient
result
pneumonia
prove
igm
igg
asthmat
includ
clinic
investig
serolog
diagnosi
influenza
viru
posit
igg
viru
posit
igg
conclus
serolog
test
reveal
lead
role
past
rsv
infect
asthma
exacerb
investig
group
asthmat
follow
adenoviru
infect
parainfluenza
viru
infect
exhal
nitric
oxid
among
bulgarian
children
asthma
exacerb
markova
r
pediatr
pediatr
consult
clinic
sofia
bulgaria
respect
associ
variant
genotyp
aat
final
proport
wheez
day
per
year
well
preval
breathless
wheez
attack
similar
normal
aat
variant
aat
group
conclus
data
alspac
birth
cohort
show
variant
aat
genotyp
associ
wheez
abstract
breathless
first
three
year
life
characterist
use
identifi
children
variant
aat
genotyp
background
asthma
heterogen
airway
diseas
variou
clinic
phenotyp
children
import
clearli
identifi
clinic
phenotyp
achiev
better
asthma
manag
predict
prognosi
investig
asthma
phenotyp
remain
rare
understood
korea
studi
aim
identifi
phenotyp
asthma
korean
schoolag
children
method
enrol
children
physiciandiagnos
asthma
korean
childhood
asthma
studi
ka
cohort
prospect
followup
studi
interv
everi
visit
questionnair
survey
pulmonari
function
test
conduct
methacholin
challeng
test
blood
test
skin
prick
test
conduct
first
time
visit
classifi
children
asthma
korean
childhood
asthma
studi
ka
cohort
cluster
use
hierarch
cluster
analysi
abstract
result
cluster
analysi
ka
cohort
indic
four
asthma
phenotyp
cluster
children
character
lateonset
maledomin
atop
asthma
cluster
earlyonset
maledomin
atop
asthma
histori
bronchiol
subject
cluster
consist
pubertyonset
femaledomin
atop
asthma
lowest
lung
function
cluster
associ
earlyonset
nonatop
asthma
result
indic
korean
children
asthma
classifi
four
distinct
cluster
identif
asthma
phenotyp
may
facilit
predict
prognosi
respons
treatment
heterogen
phenotyp
asthma
abstract
random
doubleblind
placebocontrol
trial
arginin
adjunct
therapi
pediatr
patient
healthcareassoci
pneumonia
background
research
made
regard
immunomodulatori
properti
amino
acid
possess
pharmacolog
effect
pathophysiolog
abnorm
amino
acid
includ
arginin
abstract
pulmonari
outcom
moderatelypreterm
children
mp
adolesc
unknown
aim
studi
determin
longterm
effect
moder
preterm
birth
respiratori
health
respiratori
symptom
allerg
symptom
lung
function
exercis
capac
first
studi
topic
method
prospect
cohort
studi
outcom
variabl
preval
respiratori
symptom
determin
isaac
questionnair
lung
function
paramet
fvc
lci
exercis
test
paramet
maxim
workload
maxim
breath
frequenc
ventilatori
reserv
borg
score
result
children
particip
measur
mp
fullterm
ft
group
compar
age
height
weight
exercis
activ
differ
gestat
age
mp
week
ft
birth
weight
mp
ft
abstract
although
crp
may
predict
respiratori
crisi
cm
use
diagnosi
sdb
even
neg
clinic
histori
increas
studi
demonstr
earli
initi
noninvas
ventil
includ
use
bilevel
posit
airway
pressur
bipap
safe
welltoler
manag
children
acut
respiratori
distress
syndrom
despit
proven
efficaci
pilot
studi
strategi
use
bipap
asthma
patient
sever
dyspnea
yet
welladapt
thu
term
experiment
approach
guidelin
conduct
retrospect
studi
children
admit
pediatr
intens
care
unit
picu
diagnosi
sever
asthma
exacerb
statu
asthmaticu
treat
without
bipap
purpos
studi
assess
treatment
efficaci
toler
bipap
conduct
retrospect
studi
asthma
patient
admit
picu
januari
februari
patient
signific
comorbid
certain
identifi
respiratori
pathogen
exclud
patient
multipl
admiss
admiss
record
separ
medic
record
review
follow
characterist
age
present
clinic
symptom
heart
rate
hr
respiratori
rate
rr
oxygen
demand
partial
pressur
carbon
dioxid
serum
oxygen
satur
clinic
laboratori
data
chest
xray
imag
admiss
data
group
accord
bipap
use
yesno
clinic
paramet
document
select
time
interv
intervent
intervent
hour
hour
hour
hour
hour
hour
time
zero
defin
initi
bipap
ventil
bipapus
group
method
ventil
oxygen
support
picu
nonbipap
group
mannwhitney
u
test
use
analyz
serial
data
amongst
bipap
group
analyz
intervent
use
pair
ttest
data
picu
admiss
obtain
four
exclud
reason
describ
data
admiss
differ
patient
analyz
bipap
without
bipap
mean
age
admiss
month
respiratori
rate
rr
significantli
differ
treatment
group
p
hour
treatment
p
bipap
group
higher
respiratori
rate
rr
improv
significantli
ensu
time
interv
bipap
group
heart
rate
hr
analysi
signific
differ
group
time
interv
rr
hr
level
show
declin
trend
treatment
group
bipap
group
decreas
level
show
statist
signific
level
improv
significantli
use
bipap
studi
none
receiv
invas
mechan
ventil
support
picu
stay
studi
found
signific
improv
respiratori
rate
patient
bipap
support
bipap
also
welltoler
compar
mean
noninvas
ventil
oxygen
support
nebul
mask
improv
trend
also
reflect
rr
hr
similarli
group
conclus
bipap
ventil
safe
effici
relief
respiratori
symptom
children
sever
asthma
attack
rubatinaasthma
pensietinaasthma
studi
regardless
whether
experienc
episod
asthma
worsen
except
dose
group
rubatinaasthma
studi
figur
conclus
oncedaili
tiotropium
addon
ic
mainten
therapi
control
gener
improv
lung
function
patient
age
year
moder
sever
asthma
irrespect
whether
experienc
episod
asthma
worsen
trial
data
support
demonstr
broad
efficaci
tiotropium
age
group
indic
improv
lung
function
larg
consist
even
patient
experi
episod
diseas
worsen
background
littl
investig
safeti
efficaci
new
potenti
asthma
medic
young
children
year
evalu
safeti
efficaci
oncedaili
tiotropium
respimat
tior
addon
inhal
corticosteroid
ic
without
mainten
therapi
patient
age
year
persist
asthmat
symptom
method
phase
iiiii
random
doubleblind
placebo
pbo
control
parallelgroup
trial
ninotinaasthma
patient
age
year
persist
asthmat
symptom
receiv
tiotropium
tior
tior
pbo
puff
daili
week
via
respimat
inhal
addon
usual
mainten
therapi
ic
without
control
medic
primari
object
determin
safeti
tior
compar
advers
event
ae
tior
versu
pbo
primari
efficaci
endpoint
chang
weekli
mean
combin
daytim
asthma
symptom
score
baselin
week
respons
coprimari
endpoint
peak
forc
expiratori
volum
second
within
hour
postdos
peak
respons
exploratori
analys
includ
composit
exacerb
endpoint
deriv
ae
treatment
comparison
report
hazard
ratio
hr
treatment
comparison
efficaci
endpoint
exploratori
formal
hypothesi
test
perform
result
patient
random
treat
complet
treatment
period
tior
n
figur
baselin
patient
use
shortact
agonist
week
treatment
less
half
patient
use
rescu
medic
use
rescu
medic
week
percentag
day
per
week
compar
group
median
howev
differ
upper
quartil
valu
treatment
group
tior
tior
pbo
indic
pbotreat
patient
use
rescu
medic
everi
second
day
tior
patient
use
rescu
medic
everi
third
day
conclus
result
suggest
tiotropium
addon
therapi
similar
safeti
profil
pbo
preschool
children
persist
asthmat
symptom
treatment
tior
result
nonsignific
improv
efficaci
endpoint
includ
less
frequent
use
rescu
medic
compar
pbo
importantli
observ
signific
reduct
number
children
report
ae
relat
asthma
exacerb
worsen
tior
group
compar
pbo
point
toward
increas
diseas
control
addit
wellpow
trial
need
confirm
find
analyz
month
report
ae
relat
asthma
exacerb
symptom
greatest
placebo
group
spring
autumn
winter
figur
lowest
summer
dose
tiotropium
spring
autumn
peak
reduc
studi
durat
vari
week
therefor
rr
valu
consid
rather
hazard
ratio
hr
alon
result
efficaci
endpoint
risk
exacerb
gener
reduc
tiotropium
addon
treatment
compar
placebo
hr
tabl
although
chang
reach
statist
signific
tiotropium
numer
reduct
risk
exacerb
seen
trial
abstract
reach
signific
vivatinaasthma
hr
ci
analyz
patient
report
ae
relat
asthma
exacerb
symptom
also
reduct
tiotropium
versu
placebo
across
trial
rr
conclus
overal
data
show
endpoint
exacerb
ae
relat
asthma
exacerb
symptom
align
treatment
differ
detect
use
ae
report
exacerb
data
efficaci
endpoint
collect
reduct
ae
relat
asthma
exacerb
symptom
safeti
report
may
consid
use
altern
endpoint
clinician
conduct
clinic
trial
assess
efficaci
term
exacerb
pediatr
trial
sampl
size
trial
durat
may
limit
year
exampl
data
previou
adult
asthma
studi
extrapol
pediatr
asthma
clinic
trial
program
result
sever
feasibl
consider
identifi
literatur
influenc
pediatr
trial
design
rang
low
number
child
particip
clinic
research
poor
longterm
adher
clinic
trial
set
limit
pediatricspecif
resourc
research
center
lack
trial
network
pediatr
research
pediatr
trial
may
also
requir
valid
specif
endpoint
differ
age
group
associ
stage
develop
forc
expiratori
volum
second
well
accept
endpoint
clinic
trial
adult
patient
respons
alway
correl
asthma
symptom
often
appear
normal
children
asthma
tiotropium
asthma
clinic
trial
program
improv
peak
trough
follow
tiotropium
addon
therapi
compar
rang
adult
patient
pediatr
patient
figur
altern
lung
function
measur
suggest
pediatr
patient
includ
forc
expiratori
flow
pulmonari
volum
reflect
small
airway
function
vital
capac
fvc
ratio
shown
associ
asthma
sever
children
pediatr
patient
tiotropium
addon
therapi
consist
improv
trough
respons
versu
placebo
strong
associ
improv
trough
trough
pearson
correl
coeffici
improv
larg
pronounc
trough
improv
moreov
tiotropium
addon
therapi
consist
improv
trough
ratio
versu
placebo
pediatr
patient
although
high
variabl
note
adolesc
patient
sever
asthma
addit
lung
functionbas
endpoint
import
studi
patientrelev
outcom
exacerb
symptom
assess
endpoint
confirmatori
design
requir
larg
sampl
size
long
studi
durat
trial
would
requir
give
children
placebo
long
period
may
uneth
especi
pediatr
set
asthma
diseas
follow
similar
cours
adult
children
outcom
treatment
compar
partial
extrapol
concept
appli
tiotropium
asthma
clinic
trial
program
thu
adult
patient
lung
function
symptom
exacerb
endpoint
evalu
confirmatori
manner
pediatr
patient
lung
function
endpoint
evalu
confirmatori
manner
symptom
exacerb
endpoint
assess
exploratori
manner
adult
age
year
tiotropium
addon
therapi
significantli
improv
pulmonari
function
asthma
control
reduc
exacerb
risk
versu
placebo
pediatr
patient
age
year
tiotropium
addon
therapi
larg
improv
pulmonari
function
versu
placebo
trend
improv
asthma
control
reduc
exacerb
risk
versu
placebo
compar
rang
adult
patient
result
tiotropium
asthma
clinic
program
emphas
success
clinic
trial
pediatr
patient
asthma
perform
assess
lung
function
shown
reliabl
endpoint
addit
strong
posit
correl
trough
trough
respons
gener
pronounc
respons
tiotropium
asthma
clinic
program
also
demonstr
partial
extrapol
concept
may
appli
exacerb
symptom
endpoint
therebi
keep
sampl
size
studi
durat
reason
line
ethic
consider
result
exposur
passiv
smoke
present
children
household
agglomer
lower
famili
incom
lower
level
matern
patern
school
significantli
observ
expos
group
expos
popul
show
higher
frequenc
asthma
classifi
moder
greater
use
inhal
corticosteroid
greater
frequenc
diurnal
symptom
present
least
week
patient
preval
asthmat
children
expos
passiv
smoke
high
low
socioeconom
condit
confirm
expos
group
moder
sever
greater
use
inhal
corticosteroid
greater
frequenc
diurnal
symptom
observ
expos
group
effect
measur
combat
passiv
smoke
taken
immedi
essenti
strategi
control
childhood
asthma
introduct
disagr
among
spanish
pediatrician
expert
rel
asthma
diagnosi
infant
preschool
present
result
systemat
review
asthma
guidelin
answer
key
question
regard
diagnosi
asthma
infant
preschool
preliminari
step
reach
consensu
among
spanish
pediatrician
subject
specif
definit
asthma
children
year
old
possibl
diagnos
asthma
age
includ
first
year
life
necessari
perform
pulmonari
function
test
order
make
diagnosi
asthma
children
year
age
defin
object
criteria
diagnosi
asthma
children
year
old
possibl
diagnos
asthma
preschool
even
though
diseas
may
remit
year
age
later
asthma
mesh
asthma
ti
without
restrict
languag
manual
search
subsequ
perform
inclus
exclus
criteria
includ
cpg
aim
provid
diagnost
therapeut
recommend
care
children
andor
adolesc
adult
document
consid
guidelin
met
follow
criteria
provid
practic
clinic
recommend
children
adolesc
adult
collect
relat
document
support
materi
exclud
document
without
inform
regard
concept
diagnosi
asthma
childhood
includ
first
year
life
analysi
guidelin
includ
review
subject
sever
exploratori
analys
conduct
lm
particip
research
given
descript
natur
section
relat
concept
diagnosi
asthma
questionnair
design
find
guidelin
consid
diagnosi
asthma
young
children
especi
term
age
could
establish
diagnosi
premis
clinic
criteria
complementari
test
make
diagnosi
author
respond
questionnair
contribut
comment
via
email
clarifi
discrep
discrep
resolv
agreement
among
review
obtain
refer
initi
search
trip
databas
pubm
figur
manual
search
ad
guid
final
document
analyz
group
guid
given
guid
consid
integr
differ
document
whose
content
judg
complementari
nine
guidelin
refer
patient
age
pediatr
dedic
exclus
preschool
regard
question
result
guidelin
concept
definit
asthma
close
link
diagnosi
gener
guidelin
distinct
made
definit
adult
pediatr
asthma
asthma
guidelin
recogn
gener
implicitli
age
limit
establish
diagnosi
asthma
highlight
difficulti
establish
diagnosi
year
spirometri
consid
essenti
establish
diagnosi
preschool
although
difficulti
carri
inconveni
make
difficult
confirm
diagnosi
guidelin
asthma
diagnosi
preschool
children
base
subject
interpret
pediatrician
make
clinic
find
treatment
respons
exclus
altern
diagnos
also
reli
perform
complementari
test
rule
increas
probabl
diagnosi
er
guidelin
preschool
wheez
one
indic
disappear
symptom
later
year
distinguish
realli
suffer
asthma
guidelin
accept
asthma
may
remit
time
exampl
icon
japan
child
therefor
would
impedi
establish
diagnosi
conclus
appar
agreement
among
nation
intern
guidelin
consid
diagnosi
asthma
preschool
child
syndrom
establish
age
even
though
respiratori
function
test
perform
reflect
believ
therefor
good
basi
perform
consensu
formal
find
review
glutamin
branchedchain
amino
acid
gardin
barbul
amino
acid
use
sepsi
burn
surgic
trauma
patient
present
signific
decreas
plasma
arginin
level
correl
state
immunosuppress
incur
initi
insult
studi
evalu
arginin
supplement
adjuv
therapeut
option
among
patient
healthcareassoci
pneumonia
potenti
agent
specif
alter
inflammatori
respons
immun
function
individu
diseas
process
measur
indirectli
solubl
human
leukocyt
antigen
type
dr
shladr
level
object
determin
effect
adjunct
arginin
therapi
immun
statu
pediatr
patient
diagnos
healthcareassoci
pneumonia
studi
design
random
doubleblind
placebocontrol
trial
method
patient
age
month
old
year
old
admit
pediatr
er
ward
trauma
burn
unit
diagnos
first
bout
healthcareassoci
pneumonia
regardless
current
hospit
stay
empir
treat
iv
antibiot
enter
nutrit
either
per
orem
feed
tube
includ
studi
patient
enrol
studi
random
two
group
mean
computergener
random
tabl
one
group
receiv
dietari
supplement
placebo
dietari
supplement
group
receiv
larginin
mgkgday
three
time
day
per
orem
day
adjunct
appropri
intraven
antibiot
exceed
gramsday
blood
sampl
collect
recruit
subject
baselin
level
plasma
arginin
serum
shladr
repeat
blood
extract
day
supplement
treatment
healthcareassoci
pneumonia
data
encod
microsoft
excel
analyz
use
spss
variabl
numer
variabl
express
mean
standard
deviat
variabl
underw
ttest
numer
variabl
pearson
correl
also
use
test
relationship
plasma
level
larginin
shladr
level
dietari
supplement
placebo
group
result
total
patient
recruit
studi
seven
subject
withdrawn
studi
five
due
protocol
noncompli
two
deceas
due
acut
respiratori
failur
complic
underli
diseas
thu
subject
includ
subject
recruit
respect
supplement
placebo
group
signific
differ
two
group
term
age
weight
gender
use
oxygen
support
arginin
level
day
supplement
placebo
group
show
signific
differ
p
valu
arginin
level
day
supplement
group
howev
higher
level
compar
placebo
group
statist
signific
p
valu
regard
shladr
level
group
supplement
group
lower
level
day
well
supplement
day
compar
level
placebo
group
shladr
level
two
group
statist
signific
howev
shladr
level
group
set
threshold
level
henc
group
low
shladr
level
analysi
data
compar
arginin
shladr
level
day
level
supplement
day
show
supplement
group
arginin
level
baselin
day
supplement
increas
statist
signific
p
valu
placebo
group
arginin
level
baselin
day
supplement
also
increas
howev
significantli
differ
p
valu
data
arginin
shladr
level
baselin
day
day
supplement
day
compar
although
show
correl
level
arginin
shladr
group
pearson
r
valu
less
result
studi
show
preval
rate
extrapulmonari
tb
among
pediatr
admiss
year
major
case
children
age
year
old
mean
age
year
old
appear
sex
predilect
regard
extrapulmonari
tb
major
case
known
tb
diseas
tb
exposur
common
case
eptb
includ
tb
mening
present
chang
behavior
decreas
sensorium
gastrointestin
tb
present
abdomin
distent
one
case
tb
uveiti
present
whitish
lesion
cornea
eye
among
patient
discharg
improv
includ
die
tb
mening
patient
conclus
data
say
need
strengthen
nation
tb
program
term
activ
case
find
decreas
transmiss
tb
countri
initi
earli
treatment
also
need
educ
health
care
worker
identifi
possibl
case
eptb
prevent
possibl
fatal
outcom
sinc
tb
mening
poor
outcom
health
care
profession
vigil
aggress
treat
case
result
children
studi
group
children
control
group
overal
children
studi
group
children
control
group
passiv
smoke
exposur
urin
cotinin
creatinin
level
children
expos
passiv
smoke
higher
unexpos
children
signific
differ
studi
control
group
term
age
monthli
incom
number
peopl
live
home
age
mother
father
time
spent
outsid
home
p
cotinin
abstract
creatinin
level
studi
group
higher
control
group
signific
differ
age
urin
cotinin
creatinin
level
mild
sever
case
studi
group
p
children
smoke
exposur
sever
pneumonia
mild
pneumonia
roc
analysi
reveal
urin
cotinin
creatinin
threshold
ng
mg
passiv
smoke
exposur
discuss
object
shown
passiv
smoke
exposur
associ
develop
sever
pneumonia
children
present
find
consid
promis
given
threshold
valu
passiv
smoke
exposur
smoke
cessat
countri
consider
lower
previou
studi
mycoplasma
pneumonia
pneumonia
children
method
retrospect
observ
studi
np
case
caus
rmpp
hospit
hospit
januari
decemb
conduct
clinic
manifest
laboratori
data
imag
perform
hospit
cours
outcom
analyz
result
total
np
case
caus
rmpp
identifi
median
age
year
mean
length
total
fever
day
hospit
stay
day
patient
day
day
respect
abnorm
laboratori
find
elev
creactiv
protein
crp
lactat
dehydrogenas
ldh
interleukin
il
interferon
gamma
observ
mani
patient
meanwhil
pleural
fluid
characterist
associ
np
present
studi
particularli
high
valu
pleural
fluid
cell
count
ldh
protein
also
observ
patient
studi
associ
pleural
effus
high
incid
lobar
atelectasi
pulmonari
consolid
interestingli
mean
delay
time
detect
necrot
lesion
onset
symptom
day
eighti
percent
result
median
age
higher
patient
earlyonset
complic
ecx
without
ecx
differ
patient
without
lateonset
complic
lcx
median
level
lactat
dehydrogenas
ldh
creactiv
protein
ferritin
cxc
motif
ligand
cxc
motif
ligand
interleukin
il
median
percentag
neutrophil
patient
ecx
higher
without
ecx
logist
regress
analysi
ferritin
pgml
ci
pgml
ci
background
indonesia
one
highest
tuberculosi
incid
global
miliari
tuberculosi
sever
form
tuberculosi
due
lymphohematogen
spread
miliari
tuberculosi
occur
often
younger
immunocompromis
children
howev
miliari
tuberculosi
older
age
group
rare
report
histori
low
grade
fever
chronic
cough
loss
appetit
decreas
bodi
weight
nodul
neck
armpit
upper
chest
pain
sinc
year
month
nodul
becam
reddish
ruptur
discharg
pu
nodul
start
appear
found
sign
dyspnea
rale
multipl
hypertroph
crust
ulcer
skin
tract
colli
axilla
infraclavicular
region
abdomin
enlarg
due
ascit
edema
leg
clinic
marasm
kwashiorkor
tuberculin
skin
hiv
rapid
test
neg
rapid
molecular
test
detect
low
mycobacterium
tuberculosi
mtb
hypoalbuminemia
skin
biopsi
show
specif
chronic
abstract
inflammatori
granulomat
antituberculosi
therapi
att
albumin
antibiot
nutrit
therapi
administ
signific
improv
observ
week
treatment
result
overal
pediatr
tb
patient
male
femal
pulmonari
tb
common
extrapulmonari
tb
bcg
scar
present
case
histori
tb
contact
present
common
symptom
fever
cough
malnutrit
tuberculin
skin
test
posit
genexpert
posit
year
old
year
old
respect
p
conclus
incid
extrapulmonari
tb
found
higher
adolesc
histori
contact
higher
pulmonari
tb
followup
identif
late
sequela
also
studi
result
total
children
fulfil
studi
criteria
median
age
month
girl
frequent
identifi
viru
rsv
n
follow
adenoviru
n
rhinoviru
n
parainfluenza
n
influenza
n
metapneumoviru
coronaviru
n
mycoplasma
identifi
two
children
patient
one
viru
identifi
three
children
identifi
pathogen
median
time
hospit
five
day
rang
one
day
children
treat
support
measur
three
children
need
mechan
ventil
fiftythre
children
followedup
hospit
still
follow
pulmonolog
outpati
clinic
postinfecti
bronchiol
obliteran
diagnos
clinic
ct
scan
remain
recurr
wheez
andor
cough
present
pneumonia
remain
children
maintain
followup
primari
care
local
hospit
none
identifi
respiratori
sequela
object
studi
sought
identifi
risk
factor
sever
pneumonia
among
children
year
age
costa
rica
method
case
control
studi
conduct
includ
children
year
old
admit
children
hospit
costa
rica
januari
januari
sampl
size
calcul
perform
assum
level
confid
margin
error
estim
total
patient
overal
conveni
sampl
techniqu
use
select
children
sever
pneumonia
case
children
nonsever
pneumonia
control
match
age
case
control
defin
clinic
criteria
follow
recommend
medic
record
review
collect
data
sociodemograph
nutrit
statu
risk
factor
result
mean
age
patient
month
rang
month
without
signific
differ
case
control
slight
predomin
male
sex
observ
within
sever
pneumonia
group
versu
control
group
p
ethnic
also
found
highli
associ
sever
pneumonia
sinc
patient
sever
pneumonia
group
indigen
compar
none
control
group
p
bivari
analysi
malnutrit
ci
p
prematur
ci
p
lowbirth
weight
ci
p
lack
breastfeed
abstract
least
month
ci
p
comorbid
p
significantli
associ
sever
pneumonia
total
case
expos
passiv
smoke
versu
control
increas
trend
sever
pneumonia
observ
among
children
expos
tobacco
smoke
parent
although
statist
signific
ci
p
associ
found
sever
pneumonia
environment
factor
exposur
cook
smoke
prenat
smoke
live
crowd
home
within
comorbid
asthma
ci
p
condit
associ
sever
pneumonia
linear
logist
regress
show
indigen
independ
risk
factor
develop
sever
pneumonia
p
conclus
studi
found
malnutrit
lack
breastfeed
modifi
risk
factor
relat
sever
pneumonia
young
children
factor
highli
associ
sever
pneumonia
ethnic
prematur
lowbirth
weight
comorbid
although
passiv
smoke
signific
risk
factor
gener
preval
found
group
higher
mean
preval
smoke
costa
rica
hand
adequ
vaccin
least
month
breastfeed
associ
mild
diseas
better
outcom
mortal
rate
cohort
low
compar
studi
lmic
viral
infect
present
high
proport
patient
cap
studi
sinc
sever
pneumonia
prevent
clinician
public
health
author
play
signific
role
reduc
occurr
health
promot
educ
activ
effect
child
health
program
particularli
high
risk
group
purpos
case
case
emphas
import
consid
nocardia
differenti
diagnosi
pulmonari
abscess
especi
absenc
respons
empir
therapi
case
report
report
case
previous
healthi
adolesc
admit
er
histori
fever
odynophagia
vomit
cough
thorac
pain
patient
day
amoxicillinclavulan
pultac
tonsil
admiss
exud
observ
tonsil
sign
peritonsillar
abscess
pulmonari
auscult
normal
blood
test
total
white
cell
count
neutrophil
lymphocyt
serum
creactiv
protein
crp
mgl
heterophil
antibodi
test
neg
chest
xray
reveal
interstiti
infiltr
right
upper
lobe
patient
discharg
increas
dose
amoxicillinclavulan
adolesc
return
er
eight
day
later
recrudesc
fever
dyspnea
thorac
pain
blood
test
total
white
cell
count
neutrophil
lymphocyt
background
tuberculosi
tb
childhood
clinic
challeng
prevent
treatabl
diseas
common
form
pediatr
tb
pulmonari
diseas
howev
extrapulmonari
form
tb
miliari
lymphat
mening
other
also
common
particularli
children
accord
costa
rica
consid
low
tb
incid
countri
case
per
nevertheless
diseas
consid
public
health
threat
countri
costa
result
total
case
diagnos
extrapulmonari
diseas
identifi
miliari
tb
follow
case
mening
tuberculosi
tubercul
lymphaden
pleural
tb
osteoarticular
tb
gastrointestin
skin
involv
equal
proport
patient
mean
age
diagnosi
year
rang
year
slight
predomin
male
sex
preval
observ
comparison
femal
distribut
expect
major
patient
costa
rica
immigr
also
common
region
cohort
panama
case
nicaragua
case
extrapulmonari
tb
among
indigen
popul
came
panama
hiv
posit
case
found
malnutrit
present
case
inform
collect
regard
adult
index
case
avail
patient
posit
index
case
frequent
symptom
fever
miliari
case
pleural
tuberculosi
mening
present
ganglionar
diseas
miliari
tuberculosi
chronic
cough
present
case
weight
loss
case
respiratori
distress
enlarg
liver
case
lymph
conclus
epidemiolog
character
pediatr
patient
extrapulmonari
tb
help
achiev
better
diagnost
approach
popul
clear
bacteri
confirm
difficult
children
dissemin
diseas
therefor
contact
histori
clinic
featur
radiolog
tst
may
suffici
establish
diagnosi
initi
treatment
studi
although
microbiolog
isol
low
slightli
higher
similar
report
role
molecular
biolog
tb
diagnosi
import
develop
howev
studi
techniqu
avail
whole
studi
period
found
prompt
diagnosi
depend
high
index
suspicion
clinic
sign
may
nonspecif
microbiolog
confirm
difficult
furthermor
tuberculin
skin
test
chest
radiograph
may
initi
neg
mani
pediatr
patient
treatment
well
toler
patient
patient
underw
right
bilobectomi
assumpt
malign
inflammatori
pseudotumor
initi
histolog
diagnosi
howev
due
high
clinic
suspicion
primari
lung
malign
combin
partial
resect
left
lung
perform
second
revis
histolog
materi
suggest
fungal
natur
diseas
sporotrichosi
despit
absenc
clinic
sign
immunodefici
mycolog
examin
conduct
bal
microscopi
pcr
bacteriolog
cultur
galactomannan
test
revis
histolog
materi
specif
grocott
stain
perform
followup
ct
examin
nodul
left
upper
lobe
found
fig
specif
process
postop
chang
found
differenti
diagnosi
third
expert
patholog
review
histolog
sampl
request
histolog
examin
reveal
signific
lymphoplasmacyt
infiltr
lymphoid
follicl
format
peribronchi
fibrosi
vascular
obliter
fig
diseas
rare
diseas
especi
case
lung
involv
mimic
malign
infect
inflammatori
disord
isol
pulmonari
diseas
frequent
seen
middl
age
older
men
young
peopl
also
present
diseas
biopsi
requir
diagnosi
diseas
total
patient
enrol
studi
median
onset
age
mediastin
tumor
around
yearsold
male
femal
ratio
overal
mortal
rate
two
case
benign
origin
common
tumor
type
lymphoma
follow
germ
cell
tumor
neuroblastoma
thymoma
neuroblastoma
preval
girl
younger
yearsold
initi
present
patient
includ
respiratori
distress
product
cough
pleural
effus
superior
vena
cava
svc
syndrom
neck
mass
airway
compress
fever
chest
pain
pericardi
effus
lymphoma
compar
type
tumor
like
accompani
neck
mass
p
svc
syndrom
vs
p
yet
better
one
yearsurviv
rate
vs
p
abstract
pediatr
mediastin
tumor
often
involv
respiratori
system
overal
lymphoma
highli
suspect
children
present
neck
mass
svc
syndrom
common
male
teenag
lymphoma
also
better
prognosi
compar
type
malign
neuroblastoma
posterior
mediastin
origin
consid
prioriti
among
children
younger
year
old
treat
massiv
pleural
effus
defin
sourc
revis
distal
tip
vp
cathet
may
suffici
malfunct
suspect
especi
effus
massiv
clinic
pictur
suggest
cathet
infect
remov
pleural
space
reposit
back
abdomen
right
atrium
consid
disloc
show
csf
hydrothorax
recurr
posit
pressur
ventil
also
report
possibl
therapeut
approach
effect
convers
neg
intrathorac
pressur
posit
prevent
fluid
shift
clinic
symptom
tm
complet
resolv
child
age
earli
school
age
common
persist
symptom
promin
postinfecti
cough
character
bark
unusu
sound
one
third
children
tm
exercis
intoler
due
cough
also
present
respiratori
tract
infect
diminish
frequenc
sever
child
age
primari
care
physician
awar
evolut
tm
symptom
avoid
unnecessari
treatment
accord
asthma
common
chronic
diseas
among
children
therefor
surpris
child
present
chronic
respiratori
symptom
physician
latter
first
thought
probabl
therapeut
manag
would
asthma
present
case
girl
refer
clinic
treat
asthma
without
success
year
label
difficult
treat
uncontrol
asthma
past
medic
histori
follow
find
notabl
breastmilk
aspir
age
day
confirm
hypoventil
left
lung
esophag
strictur
surgic
correct
age
month
recurr
wheez
sinc
infanc
food
allergi
pet
allergi
famili
histori
elder
brother
confirm
cf
girl
born
prenat
screen
cf
test
carrier
elder
sister
epilepsi
admiss
notabl
find
differ
circumfer
thorax
left
larger
right
diminish
lung
sound
right
crackl
rale
test
found
neg
bronchodilatatori
respons
predomin
restrict
spirometri
right
lung
smaller
size
compar
left
xray
lung
cat
confirm
suspect
diagnosi
lung
hypoplasia
therapi
modifi
accord
confirm
diagnosi
asthma
control
medic
discontinu
follow
month
signific
medic
problem
note
well
asthma
exacerb
present
case
illustr
difficult
treat
asthma
patient
realli
stricken
asthma
correct
diagnosi
requir
comprehens
investigationinclud
indepth
histori
physic
examin
pulmonari
function
studi
xray
laboratori
studi
endoscopi
special
studi
eg
allergi
case
report
boy
present
hemoptysi
day
prolong
cough
month
fever
constitut
symptom
loss
weight
loss
appetit
night
sweat
pulmonari
tuberculosi
contact
antenat
histori
signific
matern
preeclampsia
sever
fetal
intrauterin
growth
retard
born
week
gestat
birth
weight
gram
respiratori
symptom
neonat
period
child
also
histori
asthma
allerg
rhiniti
first
wheez
episod
month
old
subsequ
wheez
episod
time
year
wheez
episod
preced
fever
upper
respiratori
tract
infect
symptom
respons
bronchodil
asymptomat
wheez
episod
start
inhal
corticosteroid
ic
age
year
old
return
review
present
admiss
asthma
exacerb
year
old
spirometri
demonstr
mild
bronchodil
respons
restart
ic
although
nonadher
ic
wheez
episod
infrequ
grandfath
asthma
allerg
rhiniti
smoke
home
physic
examin
includ
respiratori
system
unremark
digit
club
lymphadenopathi
abdomin
organomegali
chest
xray
reveal
right
upper
lobe
cavitari
lesion
rais
concern
pulmonari
tuberculosi
blood
sputum
investig
bacteri
fungal
mycobacteri
infect
neg
mantoux
test
human
immunodefici
viru
screen
neg
hypochrom
microcyt
anemia
hemoglobin
gdl
note
secondari
iron
defici
low
serum
iron
ferritin
elev
serum
transferrin
occult
blood
posit
stool
blood
coagul
profil
normal
although
symptom
cbpfm
usual
present
infanc
diagnosi
delay
child
cbpfm
diagnos
late
childhood
adulthood
possibl
relat
nonspecif
symptom
vagu
present
clear
asthma
symptom
wheez
child
relat
cbpfm
although
featur
atopi
followup
symptom
pulmonari
function
help
clarifi
aim
pediatr
interstiti
lung
diseas
child
associ
high
morbid
mortal
previou
studi
suggest
outcom
may
poor
especi
infant
young
children
due
failur
thrive
weight
loss
group
anorexia
difficulti
feed
increas
energi
expenditur
increas
work
breath
may
lead
failur
thrive
weight
loss
therefor
import
know
detail
effect
nutrit
mortal
morbid
child
aim
studi
assess
relationship
nutrit
statu
pulmonari
exacerb
lung
function
test
sever
diseas
child
result
studi
period
patient
includ
registri
mean
diagnost
age
year
year
malefemal
ratio
first
evalu
mean
fvc
dlco
respect
patient
pulmonari
exacerb
rang
total
diagnosi
ild
bmi
moder
neg
signific
correl
fan
sever
score
bmi
moder
posit
signific
correl
oxygen
satur
bmi
signific
correl
number
pulmonari
exacerb
lung
function
test
cohort
howev
bmi
moder
posit
correl
dlco
partial
iga
defici
report
ks
previous
report
case
classic
ks
also
partial
iga
defici
born
famili
six
individu
ks
conclus
case
describ
import
draw
attent
differenti
diagnosi
recurr
pneumonia
case
locat
present
case
due
famili
histori
tuberculosi
high
preval
diseas
brazil
tuberculosi
investig
howev
investig
neg
bronchoscopi
examin
biopsi
decis
diagnosi
young
patient
well
circumscrib
lung
mass
nonspecif
respiratori
symptom
diagnosi
inflammatori
pseudotumor
ipt
consid
eventr
diaphragm
congenit
disord
part
diaphragmat
muscl
replac
fibroelast
tissu
weaken
diaphragm
may
displac
thorax
compromis
patient
breath
complet
eventr
almost
invari
occur
left
side
rare
right
side
present
prematur
femal
infant
whose
rightsid
diaphragm
eventr
first
note
one
month
age
although
previou
cxr
film
show
normal
bilater
diaphragmat
level
femal
infant
histori
symmetr
sga
bityh
bodi
weight
g
week
gestat
multipl
congenit
anomali
refer
hospit
due
deterior
respiratori
distress
suffer
remark
chest
retract
admiss
loud
highpitch
stridor
sound
cxr
show
increas
infiltr
bilater
lung
field
roundshap
patch
rll
area
clinic
provid
support
nasal
cpap
chest
physiotherapi
respiratori
distress
stridor
sound
rll
patch
persist
therefor
arrang
bronchoscop
studi
note
sever
degre
laryngomalacia
also
examin
diaphragm
movement
fluoroscop
found
remark
eventr
deform
rightsid
diaphragm
posterior
aspect
rib
space
paradox
movement
right
diaphragm
herniat
abdomin
content
thorac
caviti
laser
therapi
reconstruct
sever
laryngomalacia
right
diaphragm
plicat
via
abdomin
approach
pull
elev
diaphragm
undertaken
improv
breath
feed
began
gain
weight
afterward
discharg
smoothli
although
diaphragm
eventr
congenit
defect
case
present
display
late
develop
right
diaphragm
eventr
one
month
age
suspect
combin
effect
diaphragm
muscl
weak
right
side
high
neg
pleural
pressur
associ
sever
laryngomalacia
date
found
literatur
report
mention
type
late
particip
report
mani
symptom
mp
adolesc
report
dri
cough
mp
vs
ft
p
hayfev
mp
vs
ft
p
ft
mp
report
wheez
dyspnea
asthma
eczema
last
twelv
month
lung
function
measur
includ
lci
within
normal
rang
group
except
pef
mp
pred
vs
ft
pred
p
mp
vs
ft
p
lower
limit
normal
mp
observ
differ
group
maxim
workload
maxim
breath
frequenc
ventilatori
reserv
borg
score
see
also
tabl
conclus
moder
preterm
birth
littl
impact
respiratori
health
adolesc
adolesc
born
mp
report
symptom
ft
mild
lung
function
abnorm
compar
ft
differ
maxim
exercis
test
physic
activ
level
improv
surviv
continu
accru
peopl
cystic
fibrosi
cf
appear
evid
sequenti
birth
cohort
observ
galectin
protein
concentr
significantli
higher
cf
patient
exacerb
ngul
stabl
period
ngul
healthi
control
subject
ngul
p
valu
concentr
significantli
higher
sputum
blood
p
signific
correl
observ
concentr
diseas
sever
sk
score
level
correl
diseas
progress
exacerb
within
month
inclus
studi
chang
radiolog
pictur
lung
function
observ
signific
correl
fvc
declin
p
analyz
progress
marker
galectin
seem
relat
airway
inflamm
cf
may
marker
lung
function
declin
mainli
vital
capac
reduct
marker
futur
exacerb
discontinu
one
child
continu
long
term
ventil
due
comorbid
asfotas
alpha
shown
improv
skelet
miner
may
direct
impact
airway
malacia
although
fulli
investig
know
least
indirectli
aid
support
growth
child
therefor
airway
calib
cartilag
rigid
also
improv
age
demonstr
case
seri
show
children
good
prognosi
time
sometim
antenat
diagnosi
multidisciplinari
approach
novel
therapi
airway
support
via
long
term
ventil
mean
children
abl
surviv
infanc
respiratori
support
remov
grown
object
purpos
case
report
summar
clinic
characterist
diagnost
workup
outcom
patient
affect
rohhad
syndrom
method
retrospect
review
patient
clinic
histori
rapidonset
obes
hypothalam
dysfunct
hypoventil
autonom
dysregul
rohhad
syndrom
infrequ
known
clinic
entiti
possibl
caus
consult
pediatr
pulmonolog
clinic
sleeprel
disord
consid
one
nocturn
hypoventil
differenti
might
also
present
chronic
progress
entiti
case
present
herein
highlight
diagnost
challeng
uncommon
diseas
final
elev
bal
concentr
substanc
p
pepsin
observ
statist
differ
war
ar
group
conclus
patient
popul
war
event
associ
signific
airway
inflamm
injuri
biochem
mechan
involv
like
complet
prevent
andor
counteract
antiacid
treatment
review
object
review
manag
differenti
diagnosi
earlyonset
pulmonari
diseas
especi
associ
vasculit
skin
rash
persist
high
system
inflammatori
marker
case
report
boy
admit
evalu
failur
thrive
start
cow
milk
feed
month
age
examin
tachypnea
breathsmin
chest
xray
abnorm
diffus
interstiti
pattern
full
term
newborn
previou
histori
interest
apart
choke
feed
cough
cyanosi
cri
mother
sister
grandmoth
celiac
mother
suffer
diabet
hypothyroid
studi
sweat
test
tuberculin
skin
test
echocardiographi
abdomin
ultrasound
normal
erythrocyt
sediment
rate
esr
mmh
igg
elev
mgdl
chest
ct
show
diffus
groundglass
opac
septal
thicken
bronchoalveolar
lavag
bal
lymphocyt
neutrophil
found
esophag
phmetri
show
sever
gastroesophag
reflux
thu
omeprazol
start
pulmonari
biopsi
month
age
reveal
septal
widen
lymphocyt
b
aggreg
interstitium
airway
serum
precipit
igg
antibodi
cow
milk
protein
posit
initi
tent
diagnosi
milkinduc
hypersensit
pulmonari
diseas
made
cow
milkfre
diet
initi
improv
growth
administ
sever
bolus
highdos
steroid
signific
respiratori
improv
observ
age
month
start
macular
rash
cheek
ear
nodul
worsen
cold
follow
month
rash
extend
becam
purpuricnecrot
skin
biopsi
show
leukocytoclast
vascul
interfac
dermat
year
old
tocilizumab
start
clear
improv
clinic
blood
testwis
nonetheless
treatment
stop
due
muscular
toxic
month
six
year
age
public
new
entiti
n
engl
j
med
patient
found
mutat
gen
savi
syndrom
diagnos
sinc
age
asymptomat
respiratori
standpoint
dyspnea
heavi
exercis
current
year
old
follow
treatment
ruxolitinib
two
year
seem
good
clinic
respons
esr
still
import
includ
interferonopathi
savi
syndrom
differenti
diagnosi
child
interstiti
lung
diseas
especi
associ
persist
increas
acutephas
reactant
level
progress
skin
damag
consumpt
maxim
exercis
within
normal
rang
larg
variabl
predict
maxim
load
achiev
predict
ventilatori
anaerob
threshold
appear
earlier
expect
case
ventilatori
breath
reserv
normal
children
puls
within
normal
rang
larg
variabl
predict
signific
heart
rhythm
abnorm
observ
vdvt
maxim
exercis
tidal
volum
maxim
exercis
increas
capac
suggest
less
effici
ventil
pe
patient
tend
tachypn
maxim
exercis
respiratori
predict
pulmonari
equival
maxim
exercis
elev
suggest
less
effect
ga
exchang
patient
sever
pe
associ
lower
maxim
load
differ
max
ventilatori
measur
respiratori
symptom
associ
lower
higher
respiratori
equival
compar
asymptomat
patient
unfortun
pediatrician
adher
guidelin
remain
low
may
attribut
lack
physician
awar
familiar
publish
guidelin
well
lack
knowledg
regard
avail
tool
essenti
pediatr
pulmonologist
manag
primarili
diseas
directli
affect
shse
adher
publish
guidelin
purpos
studi
data
regard
whether
pediatr
pulmonologist
adher
guidelin
lack
conduct
survey
assess
pediatr
pulmonologist
practic
respect
shse
screen
counsel
treatment
referr
cessat
servic
result
eighti
respons
obtain
state
alway
use
aap
accp
clinic
practic
guidelin
although
respond
report
alway
screen
counsel
refer
caregiv
zero
percent
respond
alway
prescrib
nicotin
replac
therapi
nrt
bupropion
vareniclin
respond
feel
comfort
treat
tobacco
depend
caregiv
respond
would
attend
cessat
train
cours
offer
nation
meet
conclus
discuss
compar
cohort
gener
pediatrician
rate
screen
counsel
respond
higher
rate
treatment
referr
similar
despit
morbid
shse
common
pulmonari
diseas
like
bronchopulmonari
dysplasia
cystic
fibrosi
asthma
pediatr
pulmonologist
use
avail
tool
assist
smoke
caregiv
imper
physician
treat
children
respiratori
disord
feel
confid
treat
caregiv
tobacco
depend
revis
pediatr
pulmonari
train
program
curriculum
need
includ
tobacco
cessat
train
assur
graduat
abl
activ
involv
forefront
treat
tobacco
epidem
compar
distribut
discret
variabl
two
group
chisquar
test
fisher
exact
test
appropri
perform
bartlett
test
homogen
use
determin
group
test
perform
signific
level
p
total
patient
predict
sampl
size
critic
ill
patient
recruit
studi
patient
recruit
discharg
withdrawn
control
group
studi
due
mortal
anoth
also
withdrawn
arginin
group
due
mortal
patient
die
primari
diseas
pediatr
commun
acquir
pneumonia
less
hour
admiss
statist
analysi
also
show
statist
differ
arginin
level
arginin
group
placebo
group
supplement
use
bartlett
test
p
valu
respect
degre
freedom
lack
statist
signific
may
attribut
dose
given
subject
maximum
gram
day
readmiss
advers
effect
note
arginin
supplement
effect
prevent
occurr
nosocomi
infect
patient
critic
ill
howev
studi
highli
recommend
use
higher
dose
arginin
supplement
gram
gram
encourag
even
low
dose
arginin
use
studi
result
promis
imper
perform
investig
use
high
dose
arginin
mayb
higher
dose
posit
effect
better
demonstr
statist
differ
achiev
prevent
nosocomi
infect
conclus
sever
asthmat
children
hospit
concepcion
regist
medic
histori
receiv
quantiti
radiat
stem
mainli
chest
xray
median
equal
annual
base
radiat
patient
must
follow
time
order
look
certain
secondari
effect
radiat
exposur
wang
chen
z
yang
poor
spatial
resolut
qol
questionnair
sought
demograph
two
group
compar
unpair
ttest
fisher
exact
test
pearson
chi
squar
test
correl
perform
need
result
cf
male
mean
age
year
bo
patient
mean
age
year
recruit
statist
signific
differ
found
cf
bo
patient
pulmonari
function
test
lci
qol
questionnair
score
mean
score
similar
group
compar
cf
bo
patient
respect
p
cf
patient
score
correl
neg
percent
predict
lci
r
p
small
bo
group
correl
found
correl
found
score
qol
questionnair
score
cf
bo
patient
work
focus
bm
width
sign
airway
wall
remodel
wide
age
spectrum
group
patient
investig
relationship
anthropometr
lung
function
paramet
may
determin
measur
noninvas
data
background
transit
earli
childhood
wheez
persist
asthma
link
lung
function
impair
time
littl
known
method
use
studi
lung
function
differ
age
correl
longitudin
method
sixtyfour
children
histori
hospit
bronchiol
six
month
age
prospect
studi
impuls
oscillometri
io
mean
age
year
preschool
io
result
compar
flowvolum
spirometri
fv
measur
mean
age
year
result
baselin
respiratori
system
resist
hz
show
modest
statist
signific
correl
baselin
perform
neonatologist
routin
monitor
continu
routin
throughout
procedur
specimen
immedi
taken
accur
measur
hospit
laboratori
analysi
differ
sampl
hb
sphb
evalu
linear
regress
blandaltman
analysi
result
thirtythre
infant
age
day
day
median
day
bodi
weight
rang
gram
median
gram
studi
sampl
analyz
eleven
infant
underw
second
sampl
interv
week
due
medic
necess
case
advers
event
due
measur
sphb
blood
sampl
studi
differ
sampl
hb
sphb
level
fell
mostli
within
rang
fair
correl
r
bland
altman
plot
indic
prototyp
system
tend
show
rel
high
sphb
valu
sampl
hb
level
almost
gdl
limit
agreement
discuss
correl
sphb
sampl
hb
level
good
sphb
devic
appear
feasibl
even
devic
use
neonat
infant
kg
wide
rang
hb
level
attach
sphb
devic
neonat
infant
kg
possibl
detect
anemia
faster
reduc
unnecessari
blood
test
furthermor
pulmonari
edema
circul
failur
caus
excess
blood
transfus
may
prevent
erythropoietin
therapi
given
anemia
prematur
hb
infant
weigh
less
kg
sphb
tend
exhibit
higher
valu
sampl
hb
latter
level
almost
gdl
therefor
sphb
could
underestim
anemia
sphb
measur
lower
extrem
sampl
blood
hb
taken
upper
extrem
almost
differ
valu
fact
consid
measur
locat
anywher
like
bioengin
factor
measur
play
signific
role
data
skew
although
current
access
inform
need
conclus
applic
prototyp
sphb
devic
appear
feasibl
neonat
infant
kg
wide
rang
hb
level
may
possibl
measur
pulmonari
hemodynam
condit
without
collect
blood
time
noninvas
method
howev
time
sphb
devic
still
room
improv
accuraci
level
almost
gdl
data
obtain
studi
use
refer
futur
improv
tomographi
scan
perform
tertiari
care
hospit
purpos
studi
evalu
radiat
dose
children
year
age
undergo
chest
comput
tomographi
ct
examin
radiolog
depart
tertiari
care
hospit
expos
perform
retrospect
studi
consecut
pediatr
includ
result
metaanalysi
report
figur
institut
case
continu
neg
mode
bcv
start
emerg
depart
symptom
improv
shortli
case
respiratori
rate
heart
rate
improv
minut
start
continu
neg
mode
bcv
hypercapnia
improv
less
hour
case
bcv
work
smoothli
respiratori
condit
improv
children
respiratori
distress
breath
spontan
need
artifici
respir
difficult
maintain
airway
pressur
use
bagmask
ventil
case
bagmask
ventil
unstabl
treatment
hand
bcv
requir
sedat
greater
mobil
due
batteri
power
continu
treatment
hospit
suggest
start
treatment
bcv
emerg
depart
continu
treatment
without
interrupt
transport
patient
ward
feasibl
safe
conclus
vra
rare
condit
although
deserv
known
pediatrician
gynecologist
prenat
diagnosi
seri
radiologist
diagnos
time
explor
must
take
account
level
irradi
barium
swallow
must
abandon
mri
must
take
place
radiolog
explor
method
healthi
children
recruit
randomli
select
kindergarten
around
florenc
itali
subject
histori
respiratori
symptom
assess
use
standard
questionnair
isaac
modifi
translat
italian
children
born
less
week
gestat
age
receiv
oxygen
birth
day
exclud
children
episod
wheez
ever
episod
wheez
previou
month
includ
children
respiratori
symptom
sign
time
test
spirometri
perform
spiro
cosm
spiromet
cosm
rome
itali
accord
atser
spirometri
recommend
preschool
potenti
studi
limit
number
subject
enrol
studi
confirm
valid
refer
equat
less
local
healthi
control
male
femal
would
need
valid
publish
refer
equat
degre
certainti
sinc
smaller
sampl
size
differ
zscore
may
occur
pure
chanc
furthermor
rel
inclus
flexibl
use
select
sampl
closer
realiti
popul
avoid
select
abnorm
normal
children
would
distort
studi
result
overestim
result
still
topic
mani
discuss
regard
would
normal
paramet
necessari
consid
khoo
teck
puatnat
univers
children
medic
institut
nation
univers
hospit
singapor
wee
kim
wee
school
commun
inform
nanyang
technolog
univers
singapor
singapor
backgroundobject
sleep
essenti
optim
bodi
function
nation
sleep
foundat
recommend
primari
school
children
get
hour
sleep
per
day
previou
studi
singapor
show
sleep
durat
significantli
lower
preschool
children
compar
western
popul
littl
publish
data
sleep
habit
primari
school
children
singapor
studi
aim
investig
sleep
practic
amongst
lower
primari
school
age
children
singapor
method
questionnair
survey
parent
children
age
year
old
attend
primari
school
singapor
aim
studi
aim
determin
preval
sdb
behavior
manifest
associ
risk
factor
poor
score
children
southeastern
nigerian
citi
method
communitybas
descript
studi
conduct
use
child
sleep
questionnair
srbd
children
age
month
year
consent
household
recruit
result
three
hundr
nineti
nine
proxyreport
analyz
mean
age
month
male
femal
ratio
result
averag
rate
bacteri
contamin
nicu
contamin
area
wash
sink
suction
lowest
phototherapi
oxygen
mask
respect
frequent
bacteria
isol
follow
staphylococcu
epidermidi
bacillu
subtili
acinetobact
baumannii
e
coli
isol
sensit
imipenem
ceftriaxon
vancomycin
cefepim
ciprofloxacin
wherea
resist
ampicillin
gentamicin
erythromycin
cephalexin
result
show
consider
bacteri
contamin
nicu
particular
acinetobact
baumannii
high
drug
resist
strain
isol
hospit
seem
steril
disinfect
method
hospit
perform
children
diagnosi
osa
poor
complianc
prescrib
therapi
describ
never
use
nighttim
cpap
complianc
percept
benefit
directli
relat
immedi
long
term
impact
howev
wear
cpap
report
clear
benefit
describ
treatment
moder
extrem
success
one
quarter
parent
report
recurr
chest
infect
one
third
report
concern
regard
swallow
method
observ
retrospect
studi
children
attend
healthi
child
review
clinic
month
number
hour
sleep
record
includ
differ
day
night
hour
patient
associ
percentil
accord
graph
current
use
refer
iglowstein
data
analyz
bear
mind
differ
age
rang
elabor
repres
percentil
chart
popul
boy
sleep
hour
day
percentil
vs
percentil
boy
sleep
hour
day
percentil
vs
percentil
conclus
graph
current
use
refer
sleep
repres
popul
cultur
geograph
differ
sleep
percentil
obtain
analysi
popul
clearli
differ
current
use
refer
percentil
rang
obtain
analysi
popul
clearli
lower
current
use
refer
use
graph
origin
studi
popul
would
allow
us
identifi
effect
patient
sleep
depriv
therefor
risk
develop
secondari
problem
sleep
depriv
rare
case
hemoptysi
mucoepidermoid
carcinoma
lung
boy
introduct
present
case
boy
histori
chronic
cough
hemoptysi
case
report
boy
poorli
control
asthma
treat
inhal
steroid
exacerb
present
yearlong
histori
predomin
nocturn
product
cough
associ
two
episod
hemoptysi
relev
respiratori
symptom
chest
xray
perform
reveal
right
upper
lobe
collaps
consolid
lead
referr
institut
thorough
diagnost
workup
histori
foreign
bodi
aspir
fever
night
sweat
weight
loss
underw
initi
flexibl
bronchoscopi
show
endobronchi
exophyt
nodular
lesion
right
upper
lobe
see
figur
given
longstand
histori
respiratori
symptom
area
refer
initi
diagnosi
presumpt
endobronchi
tuberculosi
nevertheless
tuberculin
skin
test
mm
ziehl
current
patient
continu
routin
surveil
thrive
well
asymptomat
lung
function
remain
stabl
conclus
among
rare
caus
hemoptysi
pediatr
pulmonologist
expect
encount
tumor
pulmonari
adenoma
carcinoma
may
present
particularli
older
children
therefor
malign
must
alway
consid
part
differenti
diagnosi
persist
hemoptysi
children
underli
chronic
lung
diseas
mucoepidermoid
carcinoma
rare
diseas
account
less
primari
malign
lung
tumor
deriv
